{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:12:37Z","timestamp":1787310757218,"version":"build-2736575974"},"reference-count":55,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gencor Pacific Ltd.","award":["AWD00035512"],"award-info":[{"award-number":["AWD00035512"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>COVID-19 infection and vaccination offer disparate levels of defense against reinfection and breakthrough infection. This study was designed to examine the effects of curcumin supplementation, specifically HydroCurc (CURC), versus placebo (CON) on circulating inflammatory biomarkers in adults who had previously been diagnosed with COVID-19 and subsequently received a primary series of monovalent vaccine doses. This study was conducted between June 2021 and May 2022. Participants were randomized to receive CURC (500 mg) or CON capsules twice daily for four weeks. Blood sampling was completed at baseline and week-4 and analyzed for biomarkers. Linear regression was utilized to examine the between-group differences in post-trial inflammatory biomarker levels, adjusting for baseline and covariates including age, sex, race\/ethnicity, and interval between COVID-19 diagnosis and trial enrollment. The sample (n = 31) was 71% female (Age 27.6 \u00b1 10.4 y). The CURC group exhibited significantly lower post-trial concentrations of proinflammatory IL-6 (\u03b2 = \u22120.52, 95%CI: \u22121.03, \u22120.014, p = 0.046) and MCP-1 (\u03b2 = \u22120.12, 95%CI: \u22120.23, \u22120.015, p = 0.027) compared to CON, adjusting for baseline and covariates. Curcumin intake confers anti-inflammatory activity and may be a promising prophylactic nutraceutical strategy for COVID-19. These results suggest that 4 weeks of curcumin supplementation resulted in significantly lower concentrations of proinflammatory cytokines in adults who recovered from COVID-19 infection and were subsequently vaccinated.<\/jats:p>","DOI":"10.3390\/nu15071548","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T02:35:26Z","timestamp":1679538926000},"page":"1548","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Curcumin Confers Anti-Inflammatory Effects in Adults Who Recovered from COVID-19 and Were Subsequently Vaccinated: A Randomized Controlled Trial"],"prefix":"10.3390","volume":"15","author":[{"given":"Samantha N.","family":"Fessler","sequence":"first","affiliation":[{"name":"College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung","family":"Chang","sequence":"additional","affiliation":[{"name":"Biodesign Institute, Arizona State University, Tempe, AZ 85281, USA"},{"name":"School of Life Sciences, Arizona State University, Tempe, AZ 85281, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4002-7497","authenticated-orcid":false,"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA"},{"name":"Biodesign Institute, Arizona State University, Tempe, AZ 85281, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9540-6860","authenticated-orcid":false,"given":"Carol S.","family":"Johnston","sequence":"additional","affiliation":[{"name":"College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"ref_1","unstructured":"WHO (2023, March 01). WHO Coronavirus Disease (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_2","unstructured":"Centers for Disease Control and Prevention (2023, March 01). COVID-19 Data and Surveillance, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covid-data\/covidview\/index.html."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1038\/s41598-021-83040-3","article-title":"Years of life lost to COVID-19 in 81 countries","volume":"11","author":"Arolas","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.15585\/mmwr.mm7104e2","article-title":"COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence\u201425 U.S. Jurisdictions, April 4\u2013December 25, 2021","volume":"71","author":"Johnson","year":"2022","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 Breakthrough Infections in Vaccinated Health Care Workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.2022.0470","article-title":"Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants","volume":"327","author":"Accorsi","year":"2022","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the Omicron Variant from Previous SARS-CoV-2 Infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMoa2110362","article-title":"Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings","volume":"385","author":"Thompson","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41591-022-02138-x","article-title":"Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave","volume":"29","author":"Tan","year":"2023","journal-title":"Nat. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/157339512798991290","article-title":"Obesity as a Model of Premature Immunosenescence","volume":"8","year":"2012","journal-title":"Curr. Immunol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.anai.2009.11.009","article-title":"Innate and adaptive immunosenescence","volume":"104","author":"Agarwal","year":"2010","journal-title":"Ann. Allergy, Asthma Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41467-021-21907-9","article-title":"Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications","volume":"12","author":"Xiao","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4143\/crt.2014.46.1.2","article-title":"Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: The Golden Pigment from Golden Spice","volume":"46","author":"Prasad","year":"2014","journal-title":"Cancer Res. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/bph.13621","article-title":"Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases","volume":"174","author":"Kunnumakkara","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1002\/jcp.27360","article-title":"Curcumin attenuates proangiogenic and proinflammatory factors in human eutopic endometrial stromal cells through the NF-\u03baB signaling pathway","volume":"234","author":"Chowdhury","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Avasarala, S., Zhang, F., Liu, G., Wang, R., London, S.D., and London, L. (2013). Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057285"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13294","DOI":"10.1096\/fj.201901047RR","article-title":"Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia","volume":"33","author":"Zhang","year":"2019","journal-title":"FASEB J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104280","DOI":"10.1016\/j.phrs.2019.104280","article-title":"Oral turmeric\/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials","volume":"146","author":"White","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"156144","DOI":"10.1016\/j.cyto.2023.156144","article-title":"Antioxidant and anti-inflammatory effects of curcumin\/turmeric supplementation in adults: A GRADE-assessed systematic review and dose\u2013response meta-analysis of randomized controlled trials","volume":"164","author":"Dehzad","year":"2023","journal-title":"Cytokine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4875636","DOI":"10.1155\/2023\/4875636","article-title":"Profiling Inflammatory Biomarkers following Curcumin Supplementation: An Umbrella Meta-Analysis of Randomized Clinical Trials","volume":"2023","author":"Naghsh","year":"2023","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: Problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e06350","DOI":"10.1016\/j.heliyon.2021.e06350","article-title":"Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19","volume":"7","author":"Thimmulappa","year":"2021","journal-title":"Heliyon"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00394-018-1766-2","article-title":"Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse\u00ae)","volume":"58","author":"Briskey","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_27","unstructured":"National Institutes of Health (2023, February 07). Clinical Spectrum of SARS-CoV-2 Infection, Available online: https:\/\/www.covid19treatmentguidelines.nih.gov\/overview\/clinical-spectrum\/."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine\u2014United States, December 2020","volume":"69","author":"Oliver","year":"2020","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_29","unstructured":"Centers for Disease Control and Prevention (2023, February 07). Stay Up to Date on COVID-19 Vaccines, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/stay-up-to-date.html?s_cid=11747:cdc%20fully%20vaccinated%20definition:sem.ga:p:RG:GM:gen:PTN:FY22."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1080\/10408398.2017.1341865","article-title":"The emerging role of curcumin for improving vascular dysfunction: A review","volume":"58","author":"Campbell","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.2147\/DDDT.S327378","article-title":"Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures","volume":"15","author":"Peng","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2017.03.014","article-title":"Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding","volume":"142","author":"Mounce","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/gutjnl-2012-304299","article-title":"Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells","volume":"63","author":"Anggakusuma","year":"2014","journal-title":"Gut"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41598-021-81462-7","article-title":"Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: Insights from computational studies","volume":"11","author":"Jena","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Xu, X.-Y., Meng, X., Li, S., Gan, R.-Y., Li, Y., and Li, H.-B. (2018). Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives. Nutrients, 10.","DOI":"10.3390\/nu10101553"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.imbio.2008.01.003","article-title":"Tumor necrosis factor-\u03b1 up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways","volume":"213","author":"Ho","year":"2008","journal-title":"Immunobiology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1152\/ajpregu.00738.2001","article-title":"Chemokines and chemokine receptors in leukocyte trafficking","volume":"283","author":"Olson","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3892\/ol.2012.1047","article-title":"Endogenous PGE2 induces MCP-1 expression via EP4\/p38 MAPK signaling in melanoma","volume":"5","author":"Tang","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.4049\/jimmunol.153.5.2052","article-title":"NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene","volume":"153","author":"Ueda","year":"1994","journal-title":"J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"32188","DOI":"10.1038\/srep32188","article-title":"Effects of IL-1\u03b2, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity","volume":"6","author":"Bester","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"21697","DOI":"10.1038\/s41598-020-78710-7","article-title":"Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19","volume":"10","author":"Holter","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00011-011-0389-3","article-title":"Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-\u03baB pathways in rat vascular smooth muscle cells","volume":"61","author":"Zhong","year":"2012","journal-title":"Inflamm. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.intimp.2017.11.009","article-title":"Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2\/4, p38\/JNK MAPK and NF-\u03baB pathways","volume":"54","author":"Dai","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/1440-1681.12848","article-title":"Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production","volume":"45","author":"Han","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jep.2010.07.026","article-title":"Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-\u03baB inhibition","volume":"136","author":"Oh","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"30235","DOI":"10.1016\/S0021-9258(17)45855-8","article-title":"Activation of transcription factor NF-\u03baB is suppressed by curcumin (diferuloylmethane)","volume":"270","author":"Singh","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.1701495","article-title":"Curcumin Suppresses IL-1\u03b2 Secretion and Prevents Inflammation through Inhibition of the NLRP3 Inflammasome","volume":"200","author":"Yin","year":"2018","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s10753-018-0823-6","article-title":"Curcumin Attenuates Airway Inflammation and Airway Remolding by Inhibiting NF-\u03baB Signaling and COX-2 in Cigarette Smoke-Induced COPD Mice","volume":"41","author":"Yuan","year":"2018","journal-title":"Inflammation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.phrs.2016.07.004","article-title":"Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Derosa","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2006-960004","article-title":"Pharmacology of Curcuma longa","volume":"57","author":"Ammon","year":"1991","journal-title":"Planta Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/1061186X.2016.1157883","article-title":"Oral bioavailability of curcumin: Problems and advancements","volume":"24","author":"Liu","year":"2016","journal-title":"J. Drug Target."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41430-021-00949-8","article-title":"Nutrition and immunity: Lessons for COVID-19","volume":"75","author":"Calder","year":"2021","journal-title":"Eur. J. Clin. Nutr."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/7\/1548\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:01:00Z","timestamp":1760122860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/7\/1548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["nu15071548"],"URL":"https:\/\/doi.org\/10.3390\/nu15071548","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]}}}